Third-Generation EGFR Inhibitors’ Safety Profiles Under Scrutiny At ASCO

 
• By Emily Hayes and Mary Jo Laffler
  
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D